Is it possible to customise the MiSeq run to do the index read after read 2 (on the read 2 strand). I've seen the Nextera protocol for dual index reads but that's not quite what I'm looking for. Thanks for any advice.
-
-
The primers and barcodes for the index read are designed to read immediately after read 1. The primer cannot bind to the reverse complement strand during read 2. If you used your own primers and barcodes, however, you may be able to get around it, but I'm not sure what the advantage of doing that is. Reading the indices at the very end also puts you at risk of not having usable data should the run encounter a problem and stop before the index read. -
Thanks. Have had to significantly customise our library due to the nature of our work so am already using custom primers and have had to move barcode from it's usual position. Getting good Read 1 and Read 2 but not index. I think I know the issue and doing the index read on the read 2 strand would likely solve it - if it is possible to programme the run to do this. If anyone has done this would be really helpful to know.Comment
-
Talk to your Illumina FAS or Tech Support. I don't know for sure but it may be possible to create a custom recipe for the MiSeq like you can for the HiSeq.Originally posted by PTW View PostComment
-
Have you considered perhaps using an inline barcode instead? This may be less of a headache than trying to hack the MiSeq recipes.Originally posted by PTW View PostComment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment